ARCUS BIOSCIENCES INC's ticker is RCUS and the CUSIP is 03969F109. A total of 188 filers reported holding ARCUS BIOSCIENCES INC in Q3 2023. The put-call ratio across all filers is 1.03 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2020 | $1,888,000 | -4.6% | 72,709 | -37.0% | 0.01% | -12.5% |
Q3 2020 | $1,978,000 | -34.2% | 115,425 | -5.0% | 0.01% | -38.5% |
Q2 2020 | $3,007,000 | +78.2% | 121,534 | 0.0% | 0.01% | +30.0% |
Q1 2020 | $1,687,000 | +37.5% | 121,534 | 0.0% | 0.01% | +42.9% |
Q4 2019 | $1,227,000 | +10.9% | 121,534 | 0.0% | 0.01% | -12.5% |
Q3 2019 | $1,106,000 | +14.5% | 121,534 | 0.0% | 0.01% | +14.3% |
Q2 2019 | $966,000 | -36.4% | 121,534 | 0.0% | 0.01% | -30.0% |
Q1 2019 | $1,518,000 | +16.0% | 121,534 | 0.0% | 0.01% | -9.1% |
Q4 2018 | $1,309,000 | -22.7% | 121,534 | 0.0% | 0.01% | 0.0% |
Q3 2018 | $1,694,000 | +13.8% | 121,534 | 0.0% | 0.01% | 0.0% |
Q2 2018 | $1,488,000 | – | 121,534 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Invus Financial Advisors, LLC | 1,612,077 | $50,877,000 | 22.64% |
Octagon Capital Advisors LP | 2,489,974 | $78,584,000 | 16.99% |
Decheng Capital Management III (Cayman), LLC | 869,790 | $27,451,000 | 8.41% |
BVF INC/IL | 3,960,948 | $125,008,000 | 5.00% |
PFM Health Sciences, LP | 3,431,010 | $108,283,000 | 4.05% |
EcoR1 Capital, LLC | 3,265,101 | $103,047,000 | 3.22% |
Alphabet Inc. | 2,563,441 | $80,902,000 | 2.62% |
Boxer Capital, LLC | 1,432,200 | $45,200,000 | 2.32% |
SECTORAL ASSET MANAGEMENT INC | 338,480 | $10,682,000 | 1.90% |
PARK CIRCLE Co | 64,000 | $2,020,000 | 1.68% |